News
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
5h
Asianet Newsable on MSNGilead Earns Analyst Praise As FDA Clears Yeztugo For Biannual HIV PreventionAnalysts at Oppenheimer, BMO, Morgan Stanley, and Mizuho weighed in with positive long-term views, though Oppenheimer flagged ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results